GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicon Hellas SA (LTS:0OKE) » Definitions » COGS-to-Revenue

Medicon Hellas (LTS:0OKE) COGS-to-Revenue : 0.00 (As of . 20)


View and export this data going back to 2007. Start your Free Trial

What is Medicon Hellas COGS-to-Revenue?

Medicon Hellas's Cost of Goods Sold for the three months ended in . 20 was €0.00 Mil. Its Revenue for the three months ended in . 20 was €0.00 Mil.

Medicon Hellas's COGS to Revenue for the three months ended in . 20 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Medicon Hellas's Gross Margin % for the three months ended in . 20 was N/A%.

Medicon Hellas COGS-to-Revenue Historical Data

The historical data trend for Medicon Hellas's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicon Hellas COGS-to-Revenue Chart

Medicon Hellas Annual Data
Trend
COGS-to-Revenue

Medicon Hellas Quarterly Data
COGS-to-Revenue

Medicon Hellas COGS-to-Revenue Calculation

Medicon Hellas's COGS to Revenue for the fiscal year that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

Medicon Hellas's COGS to Revenue for the quarter that ended in . 20 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
= /
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medicon Hellas  (LTS:0OKE) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Medicon Hellas's Gross Margin % for the three months ended in . 20 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Medicon Hellas COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Medicon Hellas's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicon Hellas (LTS:0OKE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicon Hellas SA (LTS:0OKE) » Definitions » COGS-to-Revenue
Comparable Companies
NGM:PRLD CBAI OSTO:HEMC XSAT:IDL ASX:IBX XTER:NN6 XPAR:ALTER WAR:GEN CGIX TSXV:LMD OSTO:SCIB XCNQ:CGN XCNQ:SONA XMAD:EEP OSTO:ADDV B LSE:GDR ASX:GTG ROCO:4117 NDRA BOM:540729
Traded in Other Exchanges
N/A
Address
Melitona 5-7, Gerakas, Athens, GRC, 15344
Website
http://www.mediconsa.com
Medicon Hellas SA is a manufacturer of diagnostic reagent kits, and bulk reagents and a re-manufacturer of Olympus, Nihon Kohden, and Siemens analyzers. The company's services include Refurbishment, informatics, and Diagnostic Labs.

Medicon Hellas (LTS:0OKE) Headlines

No Headlines